nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP3A5—Sulfasalazine—Crohn's disease	0.0653	0.404	CbGbCtD
Lapatinib—CYP2C19—Prednisone—Crohn's disease	0.0421	0.26	CbGbCtD
Lapatinib—ABCB1—Prednisone—Crohn's disease	0.034	0.21	CbGbCtD
Lapatinib—CYP3A4—Prednisone—Crohn's disease	0.0203	0.126	CbGbCtD
Lapatinib—ERBB2—gall bladder—Crohn's disease	0.0188	0.112	CbGeAlD
Lapatinib—ERBB2—mouth—Crohn's disease	0.0167	0.0995	CbGeAlD
Lapatinib—TAP1—mammalian vulva—Crohn's disease	0.0116	0.0688	CbGeAlD
Lapatinib—PIK3C2B—mammalian vulva—Crohn's disease	0.0108	0.0646	CbGeAlD
Lapatinib—ERBB2—epithelium—Crohn's disease	0.00973	0.0579	CbGeAlD
Lapatinib—ERBB4—epithelium—Crohn's disease	0.00973	0.0579	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—Crohn's disease	0.00937	0.0558	CbGeAlD
Lapatinib—ERBB2—skin of body—Crohn's disease	0.00925	0.055	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—Crohn's disease	0.00878	0.0522	CbGeAlD
Lapatinib—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00797	0.037	CcSEcCtD
Lapatinib—PI4KB—mammalian vulva—Crohn's disease	0.0079	0.047	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—Crohn's disease	0.00749	0.0446	CbGeAlD
Lapatinib—ERBB2—digestive system—Crohn's disease	0.0074	0.044	CbGeAlD
Lapatinib—EGFR—mammalian vulva—Crohn's disease	0.00715	0.0426	CbGeAlD
Lapatinib—TAP1—lymph node—Crohn's disease	0.00579	0.0344	CbGeAlD
Lapatinib—PIK3C2B—lymph node—Crohn's disease	0.00544	0.0323	CbGeAlD
Lapatinib—Interstitial lung disease—Azathioprine—Crohn's disease	0.00518	0.0241	CcSEcCtD
Lapatinib—Dermatitis acneiform—Prednisone—Crohn's disease	0.00517	0.024	CcSEcCtD
Lapatinib—Nail disorder—Mesalazine—Crohn's disease	0.00515	0.0239	CcSEcCtD
Lapatinib—Hepatotoxicity—Azathioprine—Crohn's disease	0.00475	0.0221	CcSEcCtD
Lapatinib—Interstitial lung disease—Mesalazine—Crohn's disease	0.00472	0.0219	CcSEcCtD
Lapatinib—Hepatotoxicity—Mesalazine—Crohn's disease	0.00433	0.0201	CcSEcCtD
Lapatinib—Neoplasm malignant—Azathioprine—Crohn's disease	0.00429	0.0199	CcSEcCtD
Lapatinib—ERBB2—lymph node—Crohn's disease	0.00423	0.0251	CbGeAlD
Lapatinib—PIK3C2B—Exemestane—Prednisone—Crohn's disease	0.00412	0.321	CbGdCrCtD
Lapatinib—Blood disorder—Mesalazine—Crohn's disease	0.004	0.0186	CcSEcCtD
Lapatinib—PI4KB—lymph node—Crohn's disease	0.00396	0.0236	CbGeAlD
Lapatinib—EGFR—lymph node—Crohn's disease	0.00358	0.0213	CbGeAlD
Lapatinib—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00353	0.0164	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisone—Crohn's disease	0.0034	0.264	CbGdCrCtD
Lapatinib—Stomatitis—Mercaptopurine—Crohn's disease	0.00336	0.0156	CcSEcCtD
Lapatinib—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00326	0.0151	CcSEcCtD
Lapatinib—Immune system disorder—Mercaptopurine—Crohn's disease	0.00279	0.013	CcSEcCtD
Lapatinib—Alopecia—Mercaptopurine—Crohn's disease	0.00273	0.0127	CcSEcCtD
Lapatinib—Malnutrition—Mercaptopurine—Crohn's disease	0.00269	0.0125	CcSEcCtD
Lapatinib—Renal failure acute—Mesalazine—Crohn's disease	0.00263	0.0122	CcSEcCtD
Lapatinib—Anaemia—Mercaptopurine—Crohn's disease	0.00249	0.0115	CcSEcCtD
Lapatinib—Leukopenia—Mercaptopurine—Crohn's disease	0.00241	0.0112	CcSEcCtD
Lapatinib—CYP2C19—digestive system—Crohn's disease	0.0023	0.0137	CbGeAlD
Lapatinib—Arthralgia—Mercaptopurine—Crohn's disease	0.00229	0.0106	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00227	0.0106	CcSEcCtD
Lapatinib—Dry skin—Mesalazine—Crohn's disease	0.00222	0.0103	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00214	0.00993	CcSEcCtD
Lapatinib—Skin disorder—Mercaptopurine—Crohn's disease	0.00213	0.0099	CcSEcCtD
Lapatinib—Anorexia—Mercaptopurine—Crohn's disease	0.00209	0.00972	CcSEcCtD
Lapatinib—Pneumonia—Azathioprine—Crohn's disease	0.00206	0.00958	CcSEcCtD
Lapatinib—Infestation—Azathioprine—Crohn's disease	0.00205	0.00953	CcSEcCtD
Lapatinib—Infestation NOS—Azathioprine—Crohn's disease	0.00205	0.00953	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.002	0.00929	CcSEcCtD
Lapatinib—Neutropenia—Mesalazine—Crohn's disease	0.00196	0.0091	CcSEcCtD
Lapatinib—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00194	0.00901	CcSEcCtD
Lapatinib—Decreased appetite—Mercaptopurine—Crohn's disease	0.00191	0.00886	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.0019	0.0088	CcSEcCtD
Lapatinib—Pneumonia—Mesalazine—Crohn's disease	0.00188	0.00873	CcSEcCtD
Lapatinib—Infestation NOS—Mesalazine—Crohn's disease	0.00187	0.00868	CcSEcCtD
Lapatinib—Infestation—Mesalazine—Crohn's disease	0.00187	0.00868	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—Crohn's disease	0.00185	0.144	CbGdCrCtD
Lapatinib—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00183	0.0085	CcSEcCtD
Lapatinib—Stomatitis—Mesalazine—Crohn's disease	0.00182	0.00846	CcSEcCtD
Lapatinib—CYP3A5—digestive system—Crohn's disease	0.00181	0.0108	CbGeAlD
Lapatinib—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00177	0.00821	CcSEcCtD
Lapatinib—Epistaxis—Mesalazine—Crohn's disease	0.00176	0.00818	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—Crohn's disease	0.00176	0.137	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—Crohn's disease	0.00174	0.135	CbGdCrCtD
Lapatinib—Immune system disorder—Azathioprine—Crohn's disease	0.00166	0.00772	CcSEcCtD
Lapatinib—Mediastinal disorder—Azathioprine—Crohn's disease	0.00166	0.00771	CcSEcCtD
Lapatinib—Connective tissue disorder—Mesalazine—Crohn's disease	0.00165	0.00765	CcSEcCtD
Lapatinib—Alopecia—Azathioprine—Crohn's disease	0.00163	0.00756	CcSEcCtD
Lapatinib—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00162	0.00751	CcSEcCtD
Lapatinib—Cardiac disorder—Mesalazine—Crohn's disease	0.00156	0.00723	CcSEcCtD
Lapatinib—Angiopathy—Mesalazine—Crohn's disease	0.00152	0.00707	CcSEcCtD
Lapatinib—Immune system disorder—Mesalazine—Crohn's disease	0.00152	0.00704	CcSEcCtD
Lapatinib—Mediastinal disorder—Mesalazine—Crohn's disease	0.00151	0.00702	CcSEcCtD
Lapatinib—Diarrhoea—Mercaptopurine—Crohn's disease	0.0015	0.00698	CcSEcCtD
Lapatinib—Alopecia—Mesalazine—Crohn's disease	0.00148	0.00688	CcSEcCtD
Lapatinib—Anaemia—Azathioprine—Crohn's disease	0.00148	0.00688	CcSEcCtD
Lapatinib—Mental disorder—Mesalazine—Crohn's disease	0.00147	0.00682	CcSEcCtD
Lapatinib—Leukopenia—Azathioprine—Crohn's disease	0.00143	0.00666	CcSEcCtD
Lapatinib—Back pain—Mesalazine—Crohn's disease	0.00141	0.00656	CcSEcCtD
Lapatinib—Vomiting—Mercaptopurine—Crohn's disease	0.0014	0.00648	CcSEcCtD
Lapatinib—Rash—Mercaptopurine—Crohn's disease	0.00138	0.00643	CcSEcCtD
Lapatinib—Dermatitis—Mercaptopurine—Crohn's disease	0.00138	0.00642	CcSEcCtD
Lapatinib—Myalgia—Azathioprine—Crohn's disease	0.00136	0.00634	CcSEcCtD
Lapatinib—Arthralgia—Azathioprine—Crohn's disease	0.00136	0.00634	CcSEcCtD
Lapatinib—CYP3A4—digestive system—Crohn's disease	0.00136	0.0081	CbGeAlD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00136	0.00629	CcSEcCtD
Lapatinib—Anaemia—Mesalazine—Crohn's disease	0.00135	0.00627	CcSEcCtD
Lapatinib—Cardiac failure—Prednisone—Crohn's disease	0.00131	0.0061	CcSEcCtD
Lapatinib—Leukopenia—Mesalazine—Crohn's disease	0.00131	0.00607	CcSEcCtD
Lapatinib—Nausea—Mercaptopurine—Crohn's disease	0.0013	0.00606	CcSEcCtD
Lapatinib—Infection—Azathioprine—Crohn's disease	0.0013	0.00604	CcSEcCtD
Lapatinib—Palpitations—Mesalazine—Crohn's disease	0.00129	0.00599	CcSEcCtD
Lapatinib—Cough—Mesalazine—Crohn's disease	0.00127	0.00592	CcSEcCtD
Lapatinib—Skin disorder—Azathioprine—Crohn's disease	0.00127	0.0059	CcSEcCtD
Lapatinib—ABCB1—epithelium—Crohn's disease	0.00127	0.00754	CbGeAlD
Lapatinib—Arthralgia—Mesalazine—Crohn's disease	0.00124	0.00577	CcSEcCtD
Lapatinib—Myalgia—Mesalazine—Crohn's disease	0.00124	0.00577	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00123	0.00573	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00119	0.00553	CcSEcCtD
Lapatinib—Anaphylactic shock—Mesalazine—Crohn's disease	0.00119	0.00553	CcSEcCtD
Lapatinib—Infection—Mesalazine—Crohn's disease	0.00118	0.0055	CcSEcCtD
Lapatinib—Dry skin—Prednisone—Crohn's disease	0.00118	0.00546	CcSEcCtD
Lapatinib—Nervous system disorder—Mesalazine—Crohn's disease	0.00117	0.00543	CcSEcCtD
Lapatinib—Skin disorder—Mesalazine—Crohn's disease	0.00116	0.00537	CcSEcCtD
Lapatinib—Anorexia—Mesalazine—Crohn's disease	0.00114	0.00527	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00113	0.00525	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00113	0.00524	CcSEcCtD
Lapatinib—ABCB1—mammalian vulva—Crohn's disease	0.0011	0.00654	CbGeAlD
Lapatinib—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00109	0.00504	CcSEcCtD
Lapatinib—Insomnia—Mesalazine—Crohn's disease	0.00108	0.005	CcSEcCtD
Lapatinib—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00107	0.00497	CcSEcCtD
Lapatinib—Dyspnoea—Mesalazine—Crohn's disease	0.00106	0.00493	CcSEcCtD
Lapatinib—Dyspepsia—Mesalazine—Crohn's disease	0.00105	0.00487	CcSEcCtD
Lapatinib—Neutropenia—Prednisone—Crohn's disease	0.00104	0.00481	CcSEcCtD
Lapatinib—Decreased appetite—Mesalazine—Crohn's disease	0.00104	0.00481	CcSEcCtD
Lapatinib—Abdominal pain—Azathioprine—Crohn's disease	0.00103	0.0048	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00103	0.00478	CcSEcCtD
Lapatinib—Fatigue—Mesalazine—Crohn's disease	0.00103	0.00477	CcSEcCtD
Lapatinib—Constipation—Mesalazine—Crohn's disease	0.00102	0.00473	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—Crohn's disease	0.000976	0.00581	CbGeAlD
Lapatinib—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000974	0.00452	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisone—Crohn's disease	0.000969	0.0045	CcSEcCtD
Lapatinib—ABCB1—digestive system—Crohn's disease	0.000964	0.00574	CbGeAlD
Lapatinib—Hypersensitivity—Azathioprine—Crohn's disease	0.000964	0.00448	CcSEcCtD
Lapatinib—Abdominal pain—Mesalazine—Crohn's disease	0.000942	0.00437	CcSEcCtD
Lapatinib—Diarrhoea—Azathioprine—Crohn's disease	0.000895	0.00416	CcSEcCtD
Lapatinib—Hypersensitivity—Mesalazine—Crohn's disease	0.000878	0.00408	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—Crohn's disease	0.000872	0.00405	CcSEcCtD
Lapatinib—Asthenia—Mesalazine—Crohn's disease	0.000855	0.00397	CcSEcCtD
Lapatinib—Pruritus—Mesalazine—Crohn's disease	0.000843	0.00391	CcSEcCtD
Lapatinib—Vomiting—Azathioprine—Crohn's disease	0.000832	0.00386	CcSEcCtD
Lapatinib—Rash—Azathioprine—Crohn's disease	0.000825	0.00383	CcSEcCtD
Lapatinib—Dermatitis—Azathioprine—Crohn's disease	0.000824	0.00383	CcSEcCtD
Lapatinib—Headache—Azathioprine—Crohn's disease	0.00082	0.00381	CcSEcCtD
Lapatinib—Diarrhoea—Mesalazine—Crohn's disease	0.000815	0.00379	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—Crohn's disease	0.000805	0.00374	CcSEcCtD
Lapatinib—Immune system disorder—Prednisone—Crohn's disease	0.000802	0.00372	CcSEcCtD
Lapatinib—Alopecia—Prednisone—Crohn's disease	0.000784	0.00364	CcSEcCtD
Lapatinib—Mental disorder—Prednisone—Crohn's disease	0.000778	0.00361	CcSEcCtD
Lapatinib—Nausea—Azathioprine—Crohn's disease	0.000777	0.00361	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—Crohn's disease	0.000773	0.00359	CcSEcCtD
Lapatinib—Vomiting—Mesalazine—Crohn's disease	0.000758	0.00352	CcSEcCtD
Lapatinib—Rash—Mesalazine—Crohn's disease	0.000751	0.00349	CcSEcCtD
Lapatinib—Dermatitis—Mesalazine—Crohn's disease	0.000751	0.00349	CcSEcCtD
Lapatinib—Headache—Mesalazine—Crohn's disease	0.000747	0.00347	CcSEcCtD
Lapatinib—Anaemia—Prednisone—Crohn's disease	0.000714	0.00332	CcSEcCtD
Lapatinib—Nausea—Mesalazine—Crohn's disease	0.000708	0.00329	CcSEcCtD
Lapatinib—Myalgia—Prednisone—Crohn's disease	0.000658	0.00305	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—Crohn's disease	0.000658	0.00305	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000653	0.00303	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisone—Crohn's disease	0.000631	0.00293	CcSEcCtD
Lapatinib—Infection—Prednisone—Crohn's disease	0.000626	0.00291	CcSEcCtD
Lapatinib—Nervous system disorder—Prednisone—Crohn's disease	0.000618	0.00287	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—Crohn's disease	0.000612	0.00284	CcSEcCtD
Lapatinib—Anorexia—Prednisone—Crohn's disease	0.000601	0.00279	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000574	0.00267	CcSEcCtD
Lapatinib—Insomnia—Prednisone—Crohn's disease	0.00057	0.00265	CcSEcCtD
Lapatinib—Dyspepsia—Prednisone—Crohn's disease	0.000555	0.00258	CcSEcCtD
Lapatinib—ABCB1—lymph node—Crohn's disease	0.000551	0.00328	CbGeAlD
Lapatinib—Decreased appetite—Prednisone—Crohn's disease	0.000548	0.00255	CcSEcCtD
Lapatinib—Fatigue—Prednisone—Crohn's disease	0.000544	0.00252	CcSEcCtD
Lapatinib—Constipation—Prednisone—Crohn's disease	0.000539	0.0025	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—Crohn's disease	0.000516	0.00239	CcSEcCtD
Lapatinib—Abdominal pain—Prednisone—Crohn's disease	0.000498	0.00231	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisone—Crohn's disease	0.000465	0.00216	CcSEcCtD
Lapatinib—Asthenia—Prednisone—Crohn's disease	0.000452	0.0021	CcSEcCtD
Lapatinib—Pruritus—Prednisone—Crohn's disease	0.000446	0.00207	CcSEcCtD
Lapatinib—Diarrhoea—Prednisone—Crohn's disease	0.000431	0.002	CcSEcCtD
Lapatinib—Vomiting—Prednisone—Crohn's disease	0.000401	0.00186	CcSEcCtD
Lapatinib—Rash—Prednisone—Crohn's disease	0.000398	0.00185	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—Crohn's disease	0.000397	0.00184	CcSEcCtD
Lapatinib—Headache—Prednisone—Crohn's disease	0.000395	0.00183	CcSEcCtD
Lapatinib—Nausea—Prednisone—Crohn's disease	0.000375	0.00174	CcSEcCtD
Lapatinib—ERBB4—Innate Immune System—TYK2—Crohn's disease	0.000141	0.00032	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAGAP—Crohn's disease	0.000141	0.000318	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RIPK2—Crohn's disease	0.000139	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ITGA4—Crohn's disease	0.000139	0.000313	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGS2—Crohn's disease	0.000138	0.000312	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—JAK2—Crohn's disease	0.000137	0.00031	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RASGRP1—Crohn's disease	0.000136	0.000308	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000136	0.000307	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—STAT3—Crohn's disease	0.000135	0.000305	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—JAK2—Crohn's disease	0.000135	0.000305	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	0.000134	0.000304	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL18—Crohn's disease	0.000134	0.000302	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TAB1—Crohn's disease	0.000133	0.000301	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RBX1—Crohn's disease	0.000132	0.000299	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL18—Crohn's disease	0.000132	0.000298	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NOD2—Crohn's disease	0.000131	0.000296	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RASGRP1—Crohn's disease	0.000131	0.000296	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD79A—Crohn's disease	0.00013	0.000295	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RBX1—Crohn's disease	0.00013	0.000294	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—Crohn's disease	0.00013	0.000294	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000129	0.000293	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PTGER4—Crohn's disease	0.000129	0.000291	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—Crohn's disease	0.000128	0.000289	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PTGER4—Crohn's disease	0.000127	0.000287	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000125	0.000283	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—Crohn's disease	0.000125	0.000282	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—SOCS1—Crohn's disease	0.000123	0.000279	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—IL6—Crohn's disease	0.000123	0.000279	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RSPO3—Crohn's disease	0.000123	0.000278	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—Crohn's disease	0.000123	0.000278	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—STAT3—Crohn's disease	0.000122	0.000277	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—TYK2—Crohn's disease	0.000122	0.000275	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—IL6—Crohn's disease	0.000121	0.000274	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000121	0.000274	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL6—Crohn's disease	0.000121	0.000273	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SMAD3—Crohn's disease	0.00012	0.000273	CbGpPWpGaD
Lapatinib—EGFR—Disease—GCKR—Crohn's disease	0.00012	0.000272	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NOD1—Crohn's disease	0.00012	0.000272	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR6—Crohn's disease	0.00012	0.00027	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2RA—Crohn's disease	0.000119	0.000269	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SMAD3—Crohn's disease	0.000118	0.000268	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—SOCS1—Crohn's disease	0.000118	0.000268	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2RA—Crohn's disease	0.000117	0.000264	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SMAD3—Crohn's disease	0.000117	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SEL1L—Crohn's disease	0.000117	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—JAK2—Crohn's disease	0.000116	0.000263	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000116	0.000262	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—UBE2D1—Crohn's disease	0.000114	0.000258	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—STAT3—Crohn's disease	0.000114	0.000258	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—Crohn's disease	0.000113	0.000255	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000113	0.000255	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RIPK2—Crohn's disease	0.000112	0.000254	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CRP—Crohn's disease	0.000112	0.000253	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—IL6—Crohn's disease	0.000111	0.000252	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.000111	0.000251	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RIPK2—Crohn's disease	0.000111	0.00025	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CRP—Crohn's disease	0.00011	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—TYK2—Crohn's disease	0.00011	0.000249	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL3—Crohn's disease	0.00011	0.000248	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CCR6—Crohn's disease	0.000109	0.000247	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—Crohn's disease	0.000109	0.000246	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000109	0.000246	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL3—Crohn's disease	0.000108	0.000244	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TLR4—Crohn's disease	0.000107	0.000243	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR9—Crohn's disease	0.000107	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Disease—SLC11A1—Crohn's disease	0.000106	0.000241	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000106	0.00024	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TLR4—Crohn's disease	0.000106	0.000239	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PTGER4—Crohn's disease	0.000105	0.000238	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—JAK2—Crohn's disease	0.000105	0.000238	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—Crohn's disease	0.000105	0.000237	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RASGRP1—Crohn's disease	0.000104	0.000236	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000104	0.000236	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ICAM1—Crohn's disease	0.000103	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000102	0.00023	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ICAM1—Crohn's disease	0.000101	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—Crohn's disease	0.0001	0.000227	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTPN2—Crohn's disease	9.99e-05	0.000226	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GPR65—Crohn's disease	9.91e-05	0.000224	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RBX1—Crohn's disease	9.88e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—Crohn's disease	9.87e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—Crohn's disease	9.85e-05	0.000223	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	9.75e-05	0.000221	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.6e-05	0.000217	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SOCS1—Crohn's disease	9.6e-05	0.000217	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTMR3—Crohn's disease	9.57e-05	0.000216	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SOCS1—Crohn's disease	9.46e-05	0.000214	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—Crohn's disease	9.43e-05	0.000213	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—Crohn's disease	9.38e-05	0.000212	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—Crohn's disease	9.33e-05	0.000211	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—Crohn's disease	9.29e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—Crohn's disease	9.29e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Disease—RBX1—Crohn's disease	9.12e-05	0.000206	CbGpPWpGaD
Lapatinib—EGFR—Disease—HSPA1B—Crohn's disease	9.12e-05	0.000206	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL3—Crohn's disease	8.97e-05	0.000203	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR4—Crohn's disease	8.91e-05	0.000202	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—Crohn's disease	8.74e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	8.74e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—Crohn's disease	8.74e-05	0.000198	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	8.7e-05	0.000197	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RASGRP1—Crohn's disease	8.67e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Immune System—UBE2D1—Crohn's disease	8.66e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—Crohn's disease	8.66e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—Crohn's disease	8.58e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—Crohn's disease	8.55e-05	0.000193	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—STAT3—Crohn's disease	8.52e-05	0.000193	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLA2G4F—Crohn's disease	8.49e-05	0.000192	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ITGA4—Crohn's disease	8.4e-05	0.00019	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RIPK2—Crohn's disease	8.4e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TYK2—Crohn's disease	8.36e-05	0.000189	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTMR3—Crohn's disease	8.29e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SMAD3—Crohn's disease	8.29e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TYK2—Crohn's disease	8.24e-05	0.000186	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ICAM1—Crohn's disease	8.2e-05	0.000186	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL3—Crohn's disease	8.19e-05	0.000185	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SMAD3—Crohn's disease	8.16e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Disease—UBE2D1—Crohn's disease	8e-05	0.000181	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—JAK2—Crohn's disease	7.98e-05	0.00018	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—Crohn's disease	7.95e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RASGRP1—Crohn's disease	7.92e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—Crohn's disease	7.9e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TYK2—Crohn's disease	7.86e-05	0.000178	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—JAK2—Crohn's disease	7.86e-05	0.000178	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—Crohn's disease	7.83e-05	0.000177	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TAB1—Crohn's disease	7.75e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	7.74e-05	0.000175	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TYK2—Crohn's disease	7.72e-05	0.000175	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—Crohn's disease	7.71e-05	0.000175	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2RA—Crohn's disease	7.68e-05	0.000174	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.62e-05	0.000172	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NOD2—Crohn's disease	7.62e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TYK2—Crohn's disease	7.61e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—Crohn's disease	7.56e-05	0.000171	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2RA—Crohn's disease	7.56e-05	0.000171	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—JAK2—Crohn's disease	7.5e-05	0.00017	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	7.48e-05	0.000169	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—FADS1—Crohn's disease	7.46e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—Crohn's disease	7.45e-05	0.000169	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTMR3—Crohn's disease	7.4e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB2—Disease—JAK2—Crohn's disease	7.37e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB4—Disease—JAK2—Crohn's disease	7.26e-05	0.000164	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTMR3—Crohn's disease	7.22e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SOCS1—Crohn's disease	7.18e-05	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR6—Crohn's disease	7.06e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—Crohn's disease	7.02e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—Crohn's disease	6.99e-05	0.000158	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—Crohn's disease	6.98e-05	0.000158	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX4—Crohn's disease	6.98e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TYK2—Crohn's disease	6.94e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—Crohn's disease	6.93e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—Crohn's disease	6.92e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—Crohn's disease	6.88e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—Crohn's disease	6.88e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—Crohn's disease	6.83e-05	0.000154	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GCKR—Crohn's disease	6.74e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—JAK2—Crohn's disease	6.62e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL18—Crohn's disease	6.46e-05	0.000146	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—FADS1—Crohn's disease	6.46e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RBX1—Crohn's disease	6.39e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2RA—Crohn's disease	6.28e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—Crohn's disease	6.28e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTGER4—Crohn's disease	6.22e-05	0.000141	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX4—Crohn's disease	6.05e-05	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—Crohn's disease	6.03e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—Crohn's disease	5.95e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—STAT3—Crohn's disease	5.86e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GCKR—Crohn's disease	5.84e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—STAT3—Crohn's disease	5.77e-05	0.00013	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—FADS1—Crohn's disease	5.76e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2RA—Crohn's disease	5.74e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Disease—SMAD3—Crohn's disease	5.72e-05	0.000129	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—FADS1—Crohn's disease	5.63e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—UBE2D1—Crohn's disease	5.6e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—STAT3—Crohn's disease	5.5e-05	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RIPK2—Crohn's disease	5.43e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—Crohn's disease	5.41e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TYK2—Crohn's disease	5.41e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB2—Disease—STAT3—Crohn's disease	5.41e-05	0.000122	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX4—Crohn's disease	5.4e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—Crohn's disease	5.39e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TYK2—Crohn's disease	5.33e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB4—Disease—STAT3—Crohn's disease	5.33e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL3—Crohn's disease	5.3e-05	0.00012	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX4—Crohn's disease	5.27e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.23e-05	0.000118	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCKR—Crohn's disease	5.21e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—Crohn's disease	5.19e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JAK2—Crohn's disease	5.16e-05	0.000117	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.14e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RASGRP1—Crohn's disease	5.12e-05	0.000116	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCKR—Crohn's disease	5.09e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JAK2—Crohn's disease	5.08e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ICAM1—Crohn's disease	4.98e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—Crohn's disease	4.76e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—Crohn's disease	4.71e-05	0.000107	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SOCS1—Crohn's disease	4.64e-05	0.000105	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—Crohn's disease	4.64e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.45e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TYK2—Crohn's disease	4.43e-05	0.0001	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—JAK2—Crohn's disease	4.22e-05	9.55e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.17e-05	9.44e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—Crohn's disease	4.09e-05	9.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TYK2—Crohn's disease	4.04e-05	9.15e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—Crohn's disease	4.03e-05	9.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMAD3—Crohn's disease	4.01e-05	9.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JAK2—Crohn's disease	3.86e-05	8.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—Crohn's disease	3.85e-05	8.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—Crohn's disease	3.84e-05	8.7e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—Crohn's disease	3.79e-05	8.56e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—Crohn's disease	3.79e-05	8.56e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—Crohn's disease	3.78e-05	8.54e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TYK2—Crohn's disease	3.73e-05	8.44e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—Crohn's disease	3.73e-05	8.44e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.73e-05	8.43e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—Crohn's disease	3.72e-05	8.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2RA—Crohn's disease	3.71e-05	8.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—Crohn's disease	3.66e-05	8.27e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.65e-05	8.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—JAK2—Crohn's disease	3.56e-05	8.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FADS1—Crohn's disease	3.47e-05	7.84e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.46e-05	7.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—Crohn's disease	3.4e-05	7.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—Crohn's disease	3.38e-05	7.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—Crohn's disease	3.38e-05	7.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—Crohn's disease	3.35e-05	7.58e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.26e-05	7.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX4—Crohn's disease	3.25e-05	7.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCKR—Crohn's disease	3.13e-05	7.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—Crohn's disease	2.83e-05	6.4e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—Crohn's disease	2.64e-05	5.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TYK2—Crohn's disease	2.61e-05	5.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—Crohn's disease	2.61e-05	5.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—Crohn's disease	2.61e-05	5.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JAK2—Crohn's disease	2.49e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—Crohn's disease	2.28e-05	5.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—Crohn's disease	2.16e-05	4.9e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—Crohn's disease	2.15e-05	4.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—Crohn's disease	1.98e-05	4.47e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.88e-05	4.25e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—Crohn's disease	1.86e-05	4.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—Crohn's disease	1.83e-05	4.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—Crohn's disease	1.83e-05	4.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—Crohn's disease	1.66e-05	3.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.63e-05	3.68e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—Crohn's disease	1.62e-05	3.66e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.45e-05	3.28e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—Crohn's disease	1.42e-05	3.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—Crohn's disease	1.28e-05	2.89e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—Crohn's disease	9.98e-06	2.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—Crohn's disease	8.73e-06	1.97e-05	CbGpPWpGaD
